Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.150
-0.010 (-0.86%)
Apr 29, 2026, 11:10 AM EDT - Market open
Revelation Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 10.7 | 6.5 | 11.99 | 5.25 | 1.27 | Upgrade
|
| Short-Term Investments | 0.06 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 10.76 | 6.5 | 11.99 | 5.25 | 1.27 | Upgrade
|
| Cash Growth | 65.54% | -45.80% | 128.28% | 312.09% | -71.63% | Upgrade
|
| Prepaid Expenses | 0.05 | 0.07 | 0.08 | 0.07 | 0.64 | Upgrade
|
| Other Current Assets | - | - | 0.07 | 0.09 | - | Upgrade
|
| Total Current Assets | 10.81 | 6.57 | 12.15 | 5.41 | 1.91 | Upgrade
|
| Property, Plant & Equipment | 0.74 | 0.06 | 0.07 | 0.09 | 0.13 | Upgrade
|
| Other Long-Term Assets | 0.03 | - | - | - | - | Upgrade
|
| Total Assets | 11.58 | 6.62 | 12.21 | 5.5 | 2.04 | Upgrade
|
| Accounts Payable | 0.58 | 0.78 | 1.36 | 0.55 | 0.6 | Upgrade
|
| Accrued Expenses | 1.4 | 1.13 | 1.15 | 0.99 | 1.53 | Upgrade
|
| Current Portion of Leases | 0.02 | - | - | - | 0.02 | Upgrade
|
| Other Current Liabilities | - | - | 3.05 | 2.91 | - | Upgrade
|
| Total Current Liabilities | 2 | 1.91 | 5.56 | 4.45 | 2.14 | Upgrade
|
| Long-Term Leases | 0.72 | - | - | - | - | Upgrade
|
| Total Liabilities | 2.72 | 1.91 | 5.56 | 4.45 | 2.14 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 58.28 | 45.21 | 32.11 | 26.4 | 14.42 | Upgrade
|
| Retained Earnings | -49.42 | -40.51 | -25.47 | -25.35 | -14.52 | Upgrade
|
| Total Common Equity | 8.86 | 4.71 | 6.65 | 1.05 | -0.1 | Upgrade
|
| Shareholders' Equity | 8.86 | 4.71 | 6.65 | 1.05 | -0.1 | Upgrade
|
| Total Liabilities & Equity | 11.58 | 6.62 | 12.21 | 5.5 | 2.04 | Upgrade
|
| Total Debt | 0.75 | - | - | - | 0.02 | Upgrade
|
| Net Cash (Debt) | 10.01 | 6.5 | 11.99 | 5.25 | 1.26 | Upgrade
|
| Net Cash Growth | 54.05% | -45.80% | 128.28% | 317.57% | -72.00% | Upgrade
|
| Net Cash Per Share | 16.13 | 454.70 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 3.72 | 0.08 | - | - | - | Upgrade
|
| Total Common Shares Outstanding | 1.58 | 0.04 | - | - | - | Upgrade
|
| Working Capital | 8.81 | 4.65 | 6.58 | 0.96 | -0.23 | Upgrade
|
| Book Value Per Share | 5.59 | 108.19 | - | - | - | Upgrade
|
| Tangible Book Value | 8.86 | 4.71 | 6.65 | 1.05 | -0.1 | Upgrade
|
| Tangible Book Value Per Share | 5.59 | 108.19 | - | - | - | Upgrade
|
| Machinery | 0.12 | 0.15 | 0.13 | 0.13 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.